Close

Moderna (MRNA) Could Offset COVID Revenue via Rare Diseases - Morgan Stanley

Go back to Moderna (MRNA) Could Offset COVID Revenue via Rare Diseases - Morgan Stanley
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 118.25 +0.18 (0.15%)
Previous Close $118.07    52 Week High $0.52 
Open $118.44    52 Week Low $0.08 
Day High $122.58    P/E N/A 
Day Low $118.08    EPS $-3.80 
Volume 3,855,262